Difficulty: Medium
Average Score: 77%
Practice
The following prostanoid is a potent inducer of platelet aggregation
Correct answer
D
Rationale
In the context of CNS Drugs Pharmacology, understanding the role of prostanoids in platelet aggregation is crucial. The correct answer is D) Thromboxane A2. Thromboxane A2 is derived from arachidonic acid and is a potent inducer of platelet aggregation. It acts by promoting platelet activation and vasoconstriction, essential processes in hemostasis and clot formation.
Prostacyclin (A) is an inhibitor of platelet aggregation and acts in opposition to thromboxane A2. Prostaglandin E2 (B) and Prostaglandin D2 (C) also do not induce platelet aggregation; instead, they have various roles in inflammation, vasodilation, and smooth muscle contraction.
In an educational context, understanding the specific functions of different prostanoids is essential for pharmacology students and healthcare professionals. Knowing the actions of each prostanoid helps in predicting their effects in various physiological and pathological conditions, guiding the selection of appropriate pharmacological interventions. Understanding the role of thromboxane A2 in platelet aggregation is particularly important in managing conditions such as cardiovascular diseases and thrombotic disorders.
Prostacyclin (A) is an inhibitor of platelet aggregation and acts in opposition to thromboxane A2. Prostaglandin E2 (B) and Prostaglandin D2 (C) also do not induce platelet aggregation; instead, they have various roles in inflammation, vasodilation, and smooth muscle contraction.
In an educational context, understanding the specific functions of different prostanoids is essential for pharmacology students and healthcare professionals. Knowing the actions of each prostanoid helps in predicting their effects in various physiological and pathological conditions, guiding the selection of appropriate pharmacological interventions. Understanding the role of thromboxane A2 in platelet aggregation is particularly important in managing conditions such as cardiovascular diseases and thrombotic disorders.